Angela Chen, - Speech-Language Pathologist in Irvine, CA

Angela Chen, is a Speech-language Pathologist based in Irvine, California. Angela Chen is licensed to practice in California (license number 14255) and her current practice location is 5050 Barranca Pkwy, Irvine, California. She can be reached at her office (for appointments etc.) via phone at (949) 936-5000.

NPI number for Angela Chen is 1093336620 and her current mailing address is 5050 Barranca Pkwy, Irvine, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1093336620.

Contact Information

Angela Chen,
5050 Barranca Pkwy,
Irvine, CA 92604-4652
(949) 936-5000
Not Available



Healthcare Provider's Profile

Full NameAngela Chen
GenderFemale
SpecialitySpeech-language Pathologist
Location5050 Barranca Pkwy, Irvine, California
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1093336620
  • Provider Enumeration Date: 05/05/2020
  • Last Update Date: 05/05/2020

Medical Identifiers

Medical identifiers for Angela Chen such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1093336620NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 14255 (California)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Angela Chen is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Angela Chen,
5050 Barranca Pkwy,
Irvine, CA 92604-4652

Ph: (949) 936-5000
Angela Chen,
5050 Barranca Pkwy,
Irvine, CA 92604-4652

Ph: (949) 936-5000

News Archive

FDA grants five-year New Chemical Entity exclusivity to VYVANSE

Shire plc, the global specialty biopharmaceutical company, announces that the Food and Drug Administration (FDA), following a thorough administrative review of governing statutory and regulatory standards and public comments, has affirmed its prior decision to grant five-year New Chemical Entity (NCE) exclusivity to lisdexamfetamine dimesylate-currently marketed by Shire U.S. Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).

Chronic use of nicotine can reinforce the rewarding effects of alcohol

When sober alcoholics are tempted to fall off the wagon, the same receptor is stimulated as is activated by nicotine in their brain.

CEL-SCI initiates Multikine Phase III trial for head and neck cancer in Poland

CEL-SCI Corporation announced today that it has commenced its global Phase III clinical trial for Multikine, the Company's flagship immunotherapy, at the Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie, Warsaw, Poland, the first clinical site in Poland and the first center in the EU.

CHMP recommends approval of NUEDEXTA for treatment of pseudobulbar affect

Avanir Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion for NUEDEXTA (dextromethorphan hydrobromide and quinidine sulfate), recommending NUEDEXTA be approved for the treatment of pseudobulbar affect, irrespective of neurologic cause.

State abortion clinic restrictions could impact women's health care access

Stateline reports that abortion opponents are advancing new clinic standards that may be impossible to meet. Abortion rights supporters fear these rules could force many clinics to close, making it more difficult for some women to get a broad array of health care services.

Read more News

› Verified 6 days ago


Speech-Language Pathologist in Irvine, CA

Ms. Linda Charley Hill, M.A.
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 18 Hillgrass, Irvine, CA 92603
Phone: 949-233-0219    
Adrienne Rzepnick, MA CCC
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 18017 Sky Park Cir Ste G, Irvine, CA 92614
Phone: 949-929-5465    Fax: 949-737-1777
Hilary Hayashi Spannagel,
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 1929 Main St Ste 103, Irvine, CA 92614
Phone: 949-229-5709    
Ms. Laura Adjunta, M.A. CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 13143 Spectrum, Irvine, CA 92618
Phone: 510-646-6304    
Mrs. Natalia M Guarino, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3301 Ansel, Irvine, CA 92618
Phone: 407-432-2866    
Leora Shaffer, MA CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4010 Barranca Pkwy Ste 220, Irvine, CA 92604
Phone: 949-857-6051    
Mrs. Stacie Christine Carrell, STACIE BATEMAN
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 46 Orange Blossom, Irvine, CA 92618
Phone: 714-943-4944    Fax: 949-271-4941

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.